Oruka Therapeutics, Inc. ORKA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s invested capital?
- Oruka Therapeutics, Inc. (ORKA) reported invested capital of $439.01M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s invested capital changed year-over-year?
- Oruka Therapeutics, Inc.'s invested capital increased by 55.6% year-over-year, from $282.1M to $439.01M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s invested capital has grown at a 189.5% compound annual growth rate (CAGR), from -$2.1M to $426.93M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).